Crucial early evolutionary step found, imaged, and ... amazingly ... works Computer History Museum software curator Al Kossow ...
FDA confirmed that data from single-arm studies in rare diseases, such as in ultra-rare deadly pediatric cancer osteosarcoma, ...
Alignment achieved on all key points surrounding non-clinical, CMC and post-market authorization confirmatory study ...
Xojo 2025r3 debuts Libraries, a major enhancement to the IDE that allows developers to package and reuse compiled classes and interface elements across Desktop, Web, Console and iOS projects.
OS Therapies announces US FDA PDUFA waiver & EMA grants Union Marketing Authorisation eligibility for OST-HERs: New York Monday, December 8, 2025, 16:00 Hrs [IST] OS Therapies Inc ...
The Keydous AJ68 is 65% mechanical keyboard with a low-profile design available in a choice of three colorways with a choice ...
Microchip’s USB PD dual-charging-port reference board demos digitally controlled smart charging applications for different ...
We continue our annual tradition of looking back at Microsoft's wins, fails, and WTF moments: its victories, failures, and ...
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, today announced it has completed its ...
Giredestrant is the only oral SERD to show superior invasive disease-free survival in the adjuvant setting, marking the first ...
– 86% (32/37) CRc and 73% (27/37) CR in newly diagnosed NPM1-m AML, with 68% (17/25) of CRc responders achieving molecular MRD negativity by central NGS – Median duration of complete response and ...